Bavarian Nordic said quarterly and annual comparisons are challenging due to the dynamic nature of outbreaks and order size. Image credit: Shutterstock/Sonia Bonet. Bavarian Nordic
US-based Metsera emerged from stealth in April this year with a $290m raise. Image credit: Shutterstock/ karen roach. Despite the competitive nature for funding in
The FDA decision comes in the wake of a negative AdCom opinion in September. Image credit: Shutterstock/ Dilok Klaisataporn. On the heels of an unfavourable
The NHS spends £2.5bn each year on smoking- related illnesses and hospitalisations. Image credit: Shutterstock/ Gorynvd. As the UK Government presses ahead with laws to
Anaphylaxis can be caused by insect stings, food, and even certain medications. Image credit: Shutterstock/ Irina Kozorog. ALK-Abelló has acquired rights to Neffy adrenaline nasal
Leqembi is forecasted to make $4.2bn globally by 2030. Image credit: Shutterstock / viewimage. Eisai has lowered the sales forecast for its Alzheimer’s drug Leqembi
Shares in the company dipped following the Q3 earnings release. Image credit: Shutterstock / Kittyfly. Novo Nordisk has reported net Q3 profits of $3.94bn (DKr27.3bn)
Shares in Vertex rose following the lifted guidance for 2024. Image credit: Shutterstock / JHVEPhoto. Vertex Pharmaceuticals has seen a 12% revenue uptick in Q3
GSK has made its largest-ever single manufacturing investment in the US. Image credit: Shutterstock/ Golden Shrimp. Following outlays for sites in the UK and Belgium
The success of Ozempic and Wegovy has catapulted Novo Nordisk to be the most valuable company in Europe. Image credit: Shutterstock / KK Stock. In